account1:13 p.m. EDT By Alistair Barr, MarketWatch SAN FRANCISCO (MarketWatch) �� Valeant Pharmaceuticals International��s $5.7 billion bid for drug maker Cephalon Inc. is the latest in an acquisition spree backed by Jeff Ubben��s activist hedge fund firm...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Activist's latest move: Cephalon
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account